The role of dietary polyphenols in tumor necrosis factor-related apoptosis inducing ligand (TRAIL)-induced apoptosis for cancer chemoprevention

European Journal of Cancer Prevention

Volumn 20, Issue 1, 2011, Pages 63-69

  Szliszka, Ewelina ^a   Krol, Wojciech ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

APIGENIN; BAICALEIN; DAIDZEIN; EPIGALLOCATECHIN GALLATE; GENISTEIN; KAEMPFEROL; LUTEOLIN; MYRICETIN; POLYPHENOL DERIVATIVE; QUERCETIN; RESVERATROL; SILIBININ; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND RECEPTOR;

APOPTOSIS; ARTICLE; CANCER CELL; CANCER CHEMOTHERAPY; CHEMOPROPHYLAXIS; DIETARY INTAKE; DRUG ACTIVITY; DRUG STRUCTURE; FOOD; HUMAN; IMMUNOCOMPETENT CELL; NEOPLASM; PRIORITY JOURNAL; PROTEIN EXPRESSION;

APOPTOSIS; DIET; FLAVONOIDS; HUMANS; NEOPLASMS; PHENOLS; SIGNAL TRANSDUCTION; TNF-RELATED APOPTOSIS-INDUCING LIGAND;

EID: 78650509737     PISSN: 09598278     EISSN: None     Source Type: Journal    
DOI: 10.1097/CEJ.0b013e32833ecc48     Document Type: Article

References (75)

1. Aggarwal BB, Bhardwaj U, Takada Y (2004). Regulation of TRAIL-induced apoptosis by ectopic expression of antiapoptotic factors. Vitam Horm 67:453-483.
2. Almasan A, Ashkenazi A (2003). Apo2L/TRAIL: Apoptosis signaling, biology and potential for cancer therapy. Cytokine Growth Factor Rev 14:337-348.
3. Ashkenazi A, Pai R, Fong S, Leung S, Lawrence D, Marsters S, et al. (1999). Safety and antitumor activity of recombinant Apo2 ligand. J Clin Invest 104:155-162.
4. Basu A, Haldar S (2009). Combinatorial effect of epigallocatechin-3- gallate and TRAIL on pancreatic cell death. Int J Oncol 34:281-286.
5. Birt DF, Hendrich S, Wang W (2001). Dietary agents in cancer prevention: Flavonoids and isoflavonoids. Pharmacol Ther 90:157-177.
6. Bossetti C, Spertini L, Parpinel M, Gnagnarella P, Lagiou P, Negri E, et al. (2005). Flavonoids and breast cancer risk in Italy. Cancer Epidemiol Biomarkers Prev 14:805-808. (Pubitemid 40478539)
7. Bronikowka J, Szliszka E, Czuba ZP, Zwolinski D, Szmydki D, Krol W (2010). The combination of TRAIL and isoflavones enhances apoptosis in cancer cells. Molecules 15:2000-2015.
8. Chen D, Dou QP (2008). Tea polyphenols and their cancer prevention and chemotherapy. Int J Mo Sci 9:1196-11206.
9. Chen L, Zhang H (2007a). Cancer preventive mechanisms of the green tea polyphenol (-)-epigallocatechin-3-gallate. Molecules 12:946-957.
10. Chen W,Wang X, Zhuang J, Zhang L, Lin Y (2007b). Induction of death receptor 5 and suppression of surviving contribute to sensitization of TRAIL-induced cytotoxicity by quercetin in non-small lung cancer cells. Carcinogenesis 28:2114-2121.
11. Delmonte P, Rader JI (2006). Analysis of isoflavones in food and dietary supplements. J AOAC Int 89:1138-1146.
12. Fulda S, Debatin KM (2004). Sensitization for tumor necrosis factor-related apoptosis-inducing ligand induced apoptosis by the chemopreventive agent resveratrol. Cancer Res 64:337-346.
13. Fulda S, Debatin KM (2005). Resveratrol-mediated sensitization to TRAILinduced apoptosis depends on death receptor and mitochondrial signaling. Eur J Cancer 41:786-798.
14. Gill C, Walsh SE, Morrissey C, Fitzpatrick JM, Watson PW (2007). Resveratrol sensitizes androgen independent prostate cancer cells to death-receptor mediated apoptosis through multiple mechanisms. Prostate 67:1641-1653.
15. Griffith TS, Lynch D (1998). TRAIL: A molecule with multiple receptors and control mechanisms. Curr Opin Immunol 10:559-563.
16. Han X, Shen T, Lou H (2007). Dietary polyphenols and their biological significance. Int J Mol Sci 8:950-988.
17. He S, Sun C, Pan Y (2008). Red wine polyphenols for cancer prevention. Int J Mol Sci 9:842-853.
18. Horinaka M, Yoshida T, Shiraishi T, Nakata S, Wakada M, Nakanishi R, et al. (2005a). The combination of TRAIL and luteolin enhances apoptosis in human cervical cancer HeLa cells. Biochem Biophys Res Commun 333: 833-838.
19. Horinaka M, Yoshida T, Shiraishi T, Nakata S, Wakada M, Nakanishi R, et al. (2005b). Luteolin induces apoptosis via death receptor 5 upregulation in human malignant tumor cells. Oncogene 24:7180-7189.
20. Horinaka M, Yoshida T, Shiraishi T, Nakata S, Wakada M, Sakai T (2006). The dietary flavonoid apigenin sensitizes malignant tumor cells to tumor necrosis factor-related apoptosis-inducing ligand. Mol Cancer Ther 5:945-951.
21. Ivanov VN, Partridge MA, Johnson GE, Huang SX, Zhou H, Hei TK (2008). Resveratrol sensitizes melanomas to TRAIL through modulation of antiapoptotic gene expression. Exp Cell Res 314:1163-1176.
22. Jakóbisiak M, Lasek W, Golla̧b J (2003). Natural mechanisms protecting against cancer. Immunol Lett 90:103-122.
23. Jedrychowski W, Maugeri U, Popiela T, Kulig J, Sochacka-Tatara E, Pac A, et al. (2010). Case-control study on beneficial effect of regular consumption of apples on colorectal cancer risk in a population with relatively low intake of fruits and vegetables. Eur J Cancer Prev 19:42-47.
24. Jin CY, Park C, Cheong J, Choi BT, Lee TH, Lee JD, et al. (2007). Genistein sensitizes TRAIL-resistant human gastric adenocarcinoma AGS cells through activation of caspase-3. Cancer Lett 257:56-64.
25. Jin CY, Park C, Kim GY, Lee SJ, Kim WJ, Choi YH (2009a). Genistein enhances TRAIL-induced apoptosis through inhibition of p38 MAPK signaling in human hepatocellular carcinoma Hep3B cells. Chem Biol Interact 180:143-150.
26. Jin CY, Park C, Moon SK, Kim GY, Kwon TK, Lee SJ, et al. (2009b). Genistein sensitizes human hepatocellular carcinoma cells to TRAIL-mediated apoptosis by enhancing Bid cleavage. Anticancer Drugs 20:713-722.
27. Jung YH, Heo J, Lee YJ, Kwon TK, Kim YH (2010). Quercetin enhances TRAILinduced apoptosis in prostate cancer cells via increased protein stability of death receptor 5. Life Sci 86:351-357.
28. Khan N, Adhami VM, Mukhtar H (2008). Apoptosis by dietary agents for prevention and treatment of cancer. Biochem Pharmacol 76:333-1339.
29. Kidd PM (2009). Bioavailability and activity of phytosome complexes from botanical polyphenols: The sylimarin, curcumin, green tea, and grape seed extracts. Altern Med Res 14:226-246.
30. Kim YH, Lee YJ (2007). TRAIL apoptosis is enhanced by quercetin through AKT dephosphorylation. J Cell Biochem 100:998-1009.
31. Kim JY, Kim EH, Park SS, Lim JH, Kwon TK, Choi KS (2008a). Quercetin sensitizes human hepatoma cells to TRAIL-induced apoptosis via Sp1- mediated DR5 upregulation and proteasome-mediated c-FLIPS downregulation. J Cell Biochem 105:1386-1398.
32. Kim YH, Lee DH, Jeong JH, Guo ZS, Lee YJ (2008b). Quercetin augments TRAIL-induced apoptotic death: Involvement of the ERK signal transduction pathway. Biochem Pharmacol 75:1946-1958.
33. Kong CK, Lam WS, Chiu LC, Ooi VE, Sun SS, Wong YS (2009). A rice bran polyphenol, cycloartenyl ferulate, elicits apoptosis in human colorectal adenocarcinoma SW480 and sensitizes metastatic SW620 cells to TRAILinduced apoptosis. Biochem Pharmacol 77:1487-1496.
34. Kroll DJ, Shaw HS, Oberlies NH (2007). Milk thistle nomenclature: why it matters in cancer research and pharmacokinetic studies. Integr Cancer Ther 6:110-119.
35. Kruyt FA (2008). TRAIL and cancer therapy. Cancer Lett 263:14-25.
36. Lee MW, Bach JH, Lee DY, Joo WS, Kim KY, Lee WB, et al. (2005).The activation of ERK1/2 via a tyrosine kinase pathway attenuates TRAIL-induced apoptosis in HeLa cells. Cancer Invest 23:586-592.
37. Lee JY, Huerta-Yepez S, Vega M, Baritaki S, Spandidos DA, Bonavida B (2007). The NO TRAIL to YES TRAIL in cancer therapy (review). Int J Oncol 31:685-691.
38. Mann CD, Neal CP, Garcea G, Manson MM, Dennison AR, Berry DP (2009). Phytochemicals as potential chemopreventive and chemotherapeutic agents in hepatocarcinogenesis. Eur J Cancer Prev 18:13-25.
39. Masters SA, Pitti RA, Sheridan JP, Ashkenazi A (1999). Control of apoptosis signaling by Apo2 ligand. Recent Prog Horm Res 54:225-234.
40. Maximo V, Lima J, Soares P, Sobrinho-Simoes M (2009). Mitochondria and cancer. Virchows Arch 454:481-495.
41. Murakami A, Ashida H, Terao J (2008). Multitargeted cancer prevention by quercetin. Cancer Lett 296:315-325.
42. Nishikawa T, Nakajima T, Moriguchi M, Jo M, Sekoguchi S, Ishii M, et al. (2006). A green tea polyphenol, epigallocatechin-3-gallate, induces apoptosis of human hepatocellular carcinoma, possibly through inhibition of Bcl-2 family proteins. J Hepatol 44:1074-1082.
43. Nozawa F, Itami A, Saruc M, Kim M, Standop J, Picha KS, et al. (2004). The combination of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL/Apo2L) and genistein is effective in inhibiting pancreatic cancer growth. Pancreas 29:45-52.
44. Pan G, O'Rourke K, Chinnaiyan AM, Gentz R, Ebner R, Ni J, et al. (1997). The receptor for the cytotoxic ligand TRAIL. Science 276:111-113.
45. Patel D, Shukla S, Gupta S (2007). Apigenin and cancer chemoprevention: Progress, potential and promise (review). Int J Oncol 30:233-245.
46. Pereira DM, Valentao P, Pereira JA, Andrade PB (2009). Phenolics: From chemistry to biology. Molecules 14:2202-2211.
47. Pitti RM, Marsters SA, Ruppert S, Donahue CJ, Moore A, Ashkenazi A (1996). Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor receptor family. J Biol Chem 271:12687-12690. (Pubitemid 26175834)
48. Psahoulia FH, Drosopoulos KG, Doubravska L, Andera L, Pintzas A (2007). Quercetin enhances TRAIL-mediated apoptosis in colon cancer cells by inducing the accumulation receptors in lipid rafts. Mol Cancer Ther 6:2591-2599.
49. Ramos S (2007). Effects of dietary flavonoids on apoptotic pathways related to cancer chemoprevention. J Nutr Biochem 18:427-442.
50. Rossi M, Negri E, Lagiou P, Talamini R, Maso LD, Montella M, et al. (2008). Flavonoids and ovarian risk: A case-control study in Italy. Int J Cancer 123:895-898.
51. Russo GL (2007). Ins and outs of dietary phytochemicals in cancer chemoprevention. Biochem Pharmacol 74:533-544.
52. Shankar S, Chen Q, Siddiqui I, Sarva K, Srivastava RK (2007a). Sensitization of TRAIL-resistant LNCaP cells by resveratrol (3,40,5- trihydroxystilbene): Molecular mechanisms and therapeutic potential. J Mol Signal 2:27-36.
53. Shankar S, Siddiqui I, Srivastava RK (2007b). Molecular mechanisms of resveratrol (3,40,5-trihydroxy-trans-stilbene) and its interaction with TNFrelated apoptosis inducing ligand (TRAIL) in androgen-insensitive prostate cancer cells. Mol Cell Biochem 304:273-285.
54. Shi RX, Ong CN, Shen HM (2005). Protein kinase C inhibition and X-linked inhibitor of apoptosis protein degradation contribute to the sensitization effect of luteolin on tumor necrosis faector-related apoptosis-inducing ligand induced apoptosis in cancer cells. Cancer Res 65:7815-7823.
55. Siddqui IA, Malik A, Adhami VM, Asim M, Hafeez BB, Sarfaraz S, et al. (2008). Green tea polyphenol EGCG sensitizes human prostate carcinoma LNCaP cells to TRAIL-mediated apoptosis and synergistically inhibits biomarkers associated with angiogenesis and metastasis. Oncogene 27:2055-2063.
56. Siegelin MD, Habel A, Gaiser T (2008). Epigallocatechin-3-gallate (EGCGb) downregulates PEA15 and thereby augments TRAIL-mediated apoptosis in malignant glioma. Neurosci Lett 448:161-165.
57. Siegelin MD, Reuss DE, Habel A, Herold-Mende C, Deimling A (2008a). The flavonoid kaempferol sensitizes human glioma cells to TRAIL-mediated apoptosis by proteosomal degradation of survivin. Mol Cancer Ther 7: 3566-3574.
58. Siegelin MD, Siegelin Y, Habel A, Gaiser T (2009a). Genistein enhances proteosomal degradation of the short isoform of FLIP in malignant glioma cells and thereby augments TRAIL-mediated apoptosis. Neurosci Lett 453:92-97.
59. Siegelin MD, Gaiser T, Habel A, Siegelin Y (2009b). Daidzein overcomes TRAILresistance in malignant glioma cells by modulating the expression of the intrinsic apoptotic inhibitor, bcl-2. Neurosci Lett 454:223-228.
60. Siegelin MD, Gaiser T, Habel A, Siegelin Y (2009c). Myricetin sensitizes malignant glioma cells to TRAIL-mediated apoptosis by downregulation of the short isoform of FLIP and bcl-2. Cancer Lett 283:230-238.
61. Siegelin MD, Reuss DE, Habel A, Rami A, Deimling A (2009d). Quercetin promotes degradation of survivin and thereby enhances death-receptormediated apoptosis in glioma cells. Neuro Oncol 11:122-131.
62. Son YG, Kim EH, Kim JY, Kim SU, Kwon TK, Yoon AR, et al. (2007). Silibinin sensitizes human glioma cells to TRAIL-mediated apoptosis via DR5 upregulation and downregulation of cFLIP and surviving. Cancer Res 67:8274-8284.
63. Suliman A, Lam A, Datta R, Srivastava RK (2001). Intracellular mechanisms of TRAIL: Apoptosis through mitochondrial-dependent and-independent pathways. Oncogene 20:2122-2133.
64. Szliszka E, Czuba ZP, Jernas K, Krol W (2008). Dietary flavonoids sensitize HeLa cells to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL). Int J Mol Sci 9:56-64.
65. Szliszka E, Czuba ZP, Bronikowska J, Mertas A, Paradysz A, Krol W (2009a). Ethanolic extract of propolis (EEP) augments TRAIL-induced apoptotic death in prostate cancer cells. Evid Based Complement Alternat Med http://ecam. Oxfordjournals.org/cgi/content/full/nep180v1?view=long&pmid=19892808.
66. Szliszka E, Czuba ZP, Domino M, Mazur B, Zydowicz G, Krol W (2009b). Ethanolic extract of propolis (EEP) enhances the apoptosis-inducing potential of TRAIL in cancer cells. Molecules 14:738-754.
67. Szliszka E, Czuba ZP, Mazur B, Sedek L, Paradysz A, Krol W (2010). Chalcones enhance TRAIL-induced apoptosis in prostate cancer cells. Int J Mol Sci 11:1-13.
68. Tanaguchi H, Yoshida T, Horinaka M, Yasuda T, Goda AE, Konishi M, et al. (2008). Baicalein overcomes tumor necrosis factor-related apoptosis-inducing ligand resistance via two different cell specific pathways in cancer cells but not in normal cells. Cancer Res 68:8918-8927.
69. Thorburn A, Behbakht K, Ford H (2008). TRAIL receptor-targeted therapeutics: Resistance mechanisms and strategies to avoid them. Drug Resist Updat 11:17-24.
70. Walczak H, Miller RE, Ariail K, Gliniak B, Griffith TS, Kubin M, et al. (1999). Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo. Nature Med 5:157-163. (Pubitemid 29068521)
71. Wang S, El-Deiry WS (2003). TRAIL and apoptosis induction by TNF-family death receptors. Oncogene 22:8628-8633.
72. Wiley S, Schooley K, Smolak P, Din W, Huang C, Nicholl J, et al. (1995). Identification and characterization of a new member of the TNF family that induced apoptosis. Immunity 3:673-682.
73. Xiao CW (2008). Health effects of soy protein and isoflavones in humans. J Nutr 136:1244-1249.
74. Yoshida T, Konishi M, Horinaka M, Yasuda T, Goda AE, Taniguchi H, et al. (2008). Kaempferol sensitizes colon cancer cells to TRAIL-induced apoptosis. Biochem Biophys Res Commun 375:129-133.
75. Zhang L, Fang B (2005). Mechanisms of resistance to TRAIL-induced apoptosis in cancer. Cancer Gene Ther 12:228-237.